Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases

Bioorg Med Chem Lett. 2008 May 1;18(9):2788-92. doi: 10.1016/j.bmcl.2008.04.017. Epub 2008 Apr 11.

Abstract

Pentadecylidenemalonate 1b, a simplified analogue of anacardic acid, was identified as the first mixed activator/inhibitor of histone acetyltransferases (HATs). It potentiates PCAF HAT activity while inhibiting those of p300/CBP and recombinant CBP. The remarkable apoptotic effect together with the ability to selectively acetylate histone versus non-histone substrates appoint 1b as a lead for the development of anticancer drugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Alkadienes / chemistry*
  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Cell Cycle / drug effects*
  • Cell Cycle / physiology
  • Enzyme Inhibitors* / chemistry
  • Enzyme Inhibitors* / pharmacology
  • Histone Acetyltransferases / antagonists & inhibitors*
  • Humans
  • Malonates / chemistry*
  • Models, Chemical
  • U937 Cells
  • p300-CBP Transcription Factors / antagonists & inhibitors

Substances

  • Alkadienes
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Malonates
  • pentadecylidenemalonate 1b
  • Histone Acetyltransferases
  • p300-CBP Transcription Factors
  • p300-CBP-associated factor